NIH global collaborations show the percentage of grants by cancer focus area, as coded by Common Scientific Outline criteria (CSO code).

Biology: 27% of grants
Etiology: 9% of grants
Prevention: 7% of grants
Early Detection, Diagnosis, and Prognosis: 15% of grants
Treatment: 29% of grants
Cancer Control, Survivorship, and Outcomes Research: 12% of grants